aap Implantate AG

Board/Management Information • Mar 26, 2010

News Details

Ad-hoc | 26 March 2010 19:46

aap Implantate AG: Appointment of a new member of the Management Board / Early extension of CEO’s contract

aap Implantate AG / Change of Personnel

26.03.2010 19:46

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

aap Implantate AG, a medical technology company listed in the Prime
Standard segment of the Frankfurt Stock Exchange, has strengthened its top
management level. Today, the Supervisory Board has appointed Marek Hahn
with effect from April 1st as a new member of the Management Board for the
period April 1st until December 31st, 2012. Alongside Mr. Biense Visser
(CEO) and Mr. Bruke Seyoum Alemu (COO), Mr. Hahn, as Chief Finance Officer
(CFO), will be in charge of the divisions Finance, IT, Human Resources and
Administration. Also, the contract of Mr. Visser has been extended early
for another two years until the 31st of December 2012.

Since April 2007, Mr. Hahn (35) has been serving as Director of Finance for
aap. Prior to that, he worked for many years for KPMG Deutsche
Treuhandgesellschaft AG in the field of Auditing, Accounting and Executive
Consulting in various positions in Germany and foreign countries. Mr. Hahn
possesses comprehensive knowledge in the area of Finance and Controlling.

Rubino di Girolamo - Chairman of the Supervisory Board: 'We are glad to
have accomplished the early extension of Mr. Visser's contract. Being a
very successful manager and a company leader for many years, Mr. Visser
will manage, together with the extended Management team, the company's
fortune in the future. With Mr. Hahn, aap was able to bind a Finance
expert. With these decisions, aap was able to accomplish important
pre-conditions to achieve the goal of a sustainable profitable growth as
well as to develop aap to become an innovative product leader.'

Kontakt:
Bei Rückfragen wenden Sie sich bitte an:
aap Implantate AG; Nanette Hüdepohl; Head of Corporate Communications &
Legal Affairs; Lorenzweg 5; D-12099 Berlin
Tel.: ++49/30/750 19 - 133; Fax.: ++49/30/750 19 - 290; n.huedepohl@aap.de

26.03.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
Phone: +49 (0) 30 75 01 90
Fax: +49 (0) 30 75 01 91 11
E-mail: aap@aap.de
Internet: www.aap.de
ISIN: DE0005066609
WKN: 506660
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hannover, München, Hamburg, Stuttgart

End of News DGAP News-Service

---